Literature DB >> 4073019

Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease.

W M Bennett, L Elzinga, J P Pulliam, A L Rashad, J M Barry.   

Abstract

Infections involving cysts of patients with autosomal-dominant polycystic kidney disease (PCKD) are often refractory to therapy possibly because of poor penetration of antibiotics into cyst fluid. Ten patients with PCKD had blood urine and cyst fluid sampled at surgery or autopsy for antibiotic concentrations. Cysts were categorized as to their nephron site of origin by cyst fluid sodium concentrations. Drugs active against anaerobes such as metronidazole and clindamycin were present in therapeutic concentrations in both proximal and distal cysts. Ampicillin and trimethoprim-sulfamethoxazole had the best profiles considering likely infecting organisms and the antibiotic concentrations achieved in both type of cysts. It is likely that prolonged therapy with both of these drugs is necessary to insure therapeutic success. Other drugs that can be detected in cysts are lipid soluble, undergo tubular secretion, or have high pKa values. These include erythromycin, vancomycin, and cefotaxime. Aminoglycosides because of their predominant glomerular filtration and thus low filtration rate per single cystic nephron are undetectable in both proximal and distal cysts. Clinically, alternatives to aminoglycosides should be chosen for infected cysts in PCKD.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4073019     DOI: 10.1016/s0272-6386(85)80102-5

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  11 in total

1.  Cyst infection in autosomal dominant polycystic kidney disease: causative microorganisms and susceptibility to lipid-soluble antibiotics.

Authors:  T Suwabe; H Araoka; Y Ubara; K Kikuchi; R Hazue; K Mise; S Hamanoue; T Ueno; K Sumida; N Hayami; J Hoshino; A Imafuku; M Kawada; R Hiramatsu; E Hasegawa; N Sawa; K Takaichi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-08       Impact factor: 3.267

2.  The renal cyst infection caused by Salmonella enteritidis in a patient with autosomal dominant polycystic kidney disease: how did this pathogen come into the renal cysts?

Authors:  Yoshiki Tsuchiya; Yoshifumi Ubara; Tatsuya Suwabe; Junichi Hoshino; Keiichi Sumida; Rikako Hiramatsu; Eiko Hasegawa; Masayuki Yamanouchi; Noriko Hayami; Yuji Marui; Naoki Sawa; Fumi Takemoto; Kenmei Takaichi
Journal:  Clin Exp Nephrol       Date:  2010-12-04       Impact factor: 2.801

3.  Ciprofloxacin activity in cyst fluid from polycystic kidneys.

Authors:  L W Elzinga; T A Golper; A L Rashad; M E Carr; W M Bennett
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

4.  Cyst infections in patients with autosomal dominant polycystic kidney disease.

Authors:  Marion Sallée; Cédric Rafat; Jean-Ralph Zahar; Benoît Paulmier; Jean-Pierre Grünfeld; Bertrand Knebelmann; Fadi Fakhouri
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-21       Impact factor: 8.237

5.  Percutaneous Nephrolithotomy in Autosomal Dominant Polycystic Kidney Disease: Is it Different from Percutaneous Nephrolithotomy in Normal Kidney?

Authors:  Vishwajeet Singh; Rahul Janak Sinha; Dheeraj Kumar Gupta
Journal:  Curr Urol       Date:  2013-07-28

6.  The influence of renal manifestations to the progression of autosomal dominant polycystic kidney disease.

Authors:  A Idrizi; M Barbullushi; E Petrela; S Kodra; A Koroshi; N Thereska
Journal:  Hippokratia       Date:  2009-07       Impact factor: 0.471

7.  Erythropoietin in polycystic kidneys.

Authors:  K U Eckardt; M Möllmann; R Neumann; R Brunkhorst; H U Burger; G Lonnemann; H Scholz; G Keusch; B Buchholz; U Frei
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

Review 8.  Cyst infection in autosomal dominant polycystic kidney disease: our experience at Toranomon Hospital and future issues.

Authors:  Tatsuya Suwabe
Journal:  Clin Exp Nephrol       Date:  2020-07-22       Impact factor: 2.801

9.  Successfully treated Escherichia coli-induced emphysematous cyst infection with combination of intravenous antibiotics and intracystic antibiotics irrigation in a patient with autosomal dominant polycystic kidney disease.

Authors:  Hyunsuk Kim; Hayne Cho Park; Sunhwa Lee; Jungsil Lee; Chungyun Cho; Dong Ki Kim; Young-Hwan Hwang; Kook-Hwan Oh; Curie Ahn
Journal:  J Korean Med Sci       Date:  2013-06-03       Impact factor: 2.153

10.  Developments in the management of autosomal dominant polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Mir Reza Bekheirnia; Robert W Schrier
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.